STAT3 and cancer: Compared with FGFR4-Gly388 patients, FGFR4-Arg388 patients were more likely to have a higher cancer stage, poorer survival, and significantly higher levels of wave proteins (p = 0.025) and p-STAT3 (p = 0.009).